Dr. Slandzicki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
211 Cool Springs Blvd
Franklin, TN 37067Phone+1 615-778-6800Fax+1 615-778-6822
Summary
- Dr. Alex James Slandzicki, MD, is a Family Medicine specialist based in Franklin, TN, who graduated from Ohio State University College of Medicine in 1993 and completed his residency at Hamot Medical Center from 1993 to 1996. Alongside his expertise in Family Medicine, Dr. Slandzicki has experience managing conditions such as diabetic neuropathy, chronic obstructive pulmonary disease, sports medicine, diabetes mellitus, and women's health. At present, he holds multiple positions, serving as CEO at Clinical Trials Center of Middle Tennessee, LLC, and Medical Director at several healthcare institutions. Dr. Slandzicki has also published significant research papers in reputable journals, including JAMA and The Lancet Infectious Diseases, and was awarded the CMS Meaningful Use Stage 1 Certification from NextGen Ambulatory EHR in 2012.
Education & Training
Hamot Medical CenterResidency, Family Medicine, 1993 - 1996
Ohio State University College of MedicineClass of 1993
Certifications & Licensure
TN State Medical License 1998 - 2026
AL State Medical License 2020 - 2020
PA State Medical License 1994 - 1998- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
Publications & Presentations
PubMed
- 49 citationsEffect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.Susanna Naggie, David R Boulware, Christopher J Lindsell, Thomas G Stewart, Nina Gentile
JAMA. 2022-10-25 - 32 citationsEffect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.Susanna Naggie, David R Boulware, Christopher J Lindsell, Thomas G Stewart, Alex J Slandzicki
JAMA. 2023-03-21 - 52 citationsOseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, random...John H. Beigel, Yajing Bao, Joy Beeler, Weerawat Manosuthi, Alex Slandzicki
The Lancet. Infectious Diseases. 2017-12-01
Professional Memberships
- Member
- Member
- Association of Clinical ResearchMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
